13F Pro quality score
Rank #2,127 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from Health In Tech, Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $37.6M | $1.3M | 4.5% |
| FY 2024 | 10-K | $19.6M | $670.5K | 4.5% |
| FY 2023 | 10-K | $19.2M | $4.0M | 17.8% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
Health In Tech, Inc. (HIT) stock profile, AI quality score, and SEC EDGAR financial data, a Financials sector company. 13F Pro's AI-powered ranking engine scores HIT at 39.8/100 on a composite quality score built from its SEC filings, placing it at rank #2,127 of 2,925 stocks — the bottom half of the AI-ranked universe. HIT scores in the top quartile across institutional flow (98.1), revenue growth (88.4). Areas of concern include earnings quality (4.2) and revenue scale (6.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 25.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Health In Tech, Inc. reports quarterly revenue of $8.1M, net income of $-2.5M, an operating margin of -41.0%. Top institutional holders of HIT by reported 13-F value include Whetstone Capital Advisors, Mink Brook Asset Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. HIT trades on the Nasdaq exchange and files with the SEC under CIK 2019505. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HIT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Health In Tech, Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 2019505 →